We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Scholar Rock
SRRK
$6.44B
| $783K | ﹤0.01% |
27,108
+1,503
| +6% | +$46K |
|
|
KE
2352
Kimball Electronics
KE
$628M
| $780K | ﹤0.01% |
35,872
-4,416
| -11% | -$99.4K |
|
2353
Dyne Therapeutics
DYN
$4.9B
| $778K | ﹤0.01% |
36,990
+25,442
| +220% | +$478K |
|
2354
MediaAlpha
MAX
$821M
| $777K | ﹤0.01% |
18,459
+7,476
| +68% | +$299K |
|
|
FRTA
2355
DELISTED
Forterra, Inc
FRTA
| $777K | ﹤0.01% |
33,033
+1,093
| +3% | +$25.6K |
|
|
GTS
2356
DELISTED
Triple-S Management Corporation
GTS
| $777K | ﹤0.01% |
34,889
-3,316
| -9% | -$82.3K |
|
|
RADI
2357
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $775K | ﹤0.01% |
+53,451
| New | +$799K |
|
|
APTS
2358
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $774K | ﹤0.01% |
79,414
-5,965
| -7% | -$60.5K |
|
2359
Barrett Business Services
BBSI
$804M
| $770K | ﹤0.01% |
42,420
-4,860
| -10% | -$89K |
|
|
PTVE
2360
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $770K | ﹤0.01% |
51,068
+4,136
| +9% | +$62.1K |
|
2361
Akebia Therapeutics
AKBA
$252M
| $769K | ﹤0.01% |
202,959
+28,718
| +16% | +$96.7K |
|
|
SP
2362
DELISTED
SP Plus Corporation
SP
| $767K | ﹤0.01% |
25,080
-12,831
| -34% | -$420K |
|
2363
Amneal Pharmaceuticals
AMRX
$5.79B
| $766K | ﹤0.01% |
149,596
-4,654
| -3% | -$26.5K |
|
|
AUD
2364
DELISTED
Audacy, Inc.
AUD
| $766K | ﹤0.01% |
177,756
-20,042
| -10% | -$92.1K |
|
|
PLYM
2365
DELISTED
Plymouth Industrial REIT
PLYM
| $765K | ﹤0.01% |
38,233
+15,652
| +69% | +$296K |
|
2366
First Financial Corp
THFF
$969M
| $761K | ﹤0.01% |
18,637
-3,270
| -15% | -$145K |
|
2367
Recursion Pharmaceuticals
RXRX
$1.72B
| $760K | ﹤0.01% |
+20,818
| New | +$616K |
|
2368
Construction Partners
ROAD
$6.77B
| $759K | ﹤0.01% |
24,163
-8,160
| -25% | -$256K |
|
|
HGEN
2369
DELISTED
HUMANIGEN, INC.
HGEN
| $759K | ﹤0.01% |
+43,660
| New | +$796K |
|
2370
SkinHealth Systems
SKIN
$85.7M
| $758K | ﹤0.01% |
+45,122
| New | +$617K |
|
2371
Transmedics
TMDX
$2.91B
| $756K | ﹤0.01% |
22,789
-651
| -3% | -$18K |
|
|
GAN
2372
DELISTED
GAN Ltd
GAN
| $751K | ﹤0.01% |
45,691
+15,633
| +52% | +$276K |
|
2373
A10 Networks
ATEN
$1.93B
| $747K | ﹤0.01% |
66,304
-1,094
| -2% | -$10.6K |
|
2374
Nordic American Tanker
NAT
$1.37B
| $742K | ﹤0.01% |
226,342
-22,751
| -9% | -$76.9K |
|
|
CMRX
2375
DELISTED
Chimerix, Inc.
CMRX
| $742K | ﹤0.01% |
92,736
-7,250
| -7% | -$60.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.